Ullem Scott B., CFO of Edwards Lifesciences ($EW), sold over $4.5 million in company shares through 7 open market transactions in the past year. His latest sale occurred on March 11, 2026. These sales rank 2092nd among 11,678 insiders, below the average of $8.6 million per person and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 190 | $131.55 | 8,791.0000 | 201,000,000 | 2.21% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 13000 | $59.26 | 319,017.0000 | 658,200,000 | 4.25% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5099 | $84.46 | 313,918.0000 | 658,200,000 | 1.60% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7901 | $85.21 | 306,017.0000 | 658,200,000 | 2.52% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 13000 | $0.00 | 26,000.0000 | 658,200,000 | 33.33% | 0.00% |
| Feb. 16, 2026 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 199 | $75.87 | 306,017.0000 | 658,200,000 | 0.06% | 0.00% |
| Dec. 31, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 212 | $117.63 | 8,601.0000 | 201,000,000 | 2.53% | 0.00% |
| Dec. 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7700 | $59.26 | 313,916.0000 | 658,200,000 | 2.51% | 0.00% |
| Dec. 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7700 | $84.47 | 306,216.0000 | 658,200,000 | 2.45% | 0.00% |
| Dec. 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7700 | $0.00 | 39,000.0000 | 658,200,000 | 16.49% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 13000 | $0.00 | 46,700.0000 | 658,200,000 | 21.78% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 10026 | $83.02 | 306,216.0000 | 658,200,000 | 3.17% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 2974 | $83.30 | 316,242.0000 | 658,200,000 | 0.93% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 13000 | $59.26 | 319,216.0000 | 658,200,000 | 4.25% | 0.00% |
| Sept. 30, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 252 | $99.17 | 8,389.0000 | 201,000,000 | 3.10% | 0.00% |
| June 30, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 307 | $81.20 | 8,137.0000 | 201,000,000 | 3.92% | 0.00% |
| May 21, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 3780 | $0.00 | 7,830.0000 | 201,000,000 | 93.33% | 0.00% |
| May 16, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | F | Common Stock | 1070 | $83.62 | 4,050.0000 | 201,000,000 | 20.90% | 0.00% |
| May 11, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1200 | $73.68 | 306,216.0000 | 655,900,000 | 0.39% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Performance Rights | 13400 | $0.00 | 13,400.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Employee Stock Option (Right to Acquire) | 75200 | $0.00 | 75,200.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $74.40 | 307,416.0000 | 655,900,000 | 3.53% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 318,666.0000 | 655,900,000 | 3.66% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Common Stock | 13400 | $0.00 | 307,416.0000 | 655,900,000 | 4.56% | 0.00% |
| May 7, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1406 | $74.92 | 294,016.0000 | 655,900,000 | 0.48% | 0.00% |
| May 4, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 648 | $75.65 | 295,422.0000 | 655,900,000 | 0.22% | 0.00% |
| May 3, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 635 | $75.65 | 296,070.0000 | 655,900,000 | 0.21% | 0.00% |
| March 31, 2025 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 229 | $104.92 | 5,120.0000 | 201,000,000 | 4.68% | 0.00% |
| March 26, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 307,955.0000 | 654,800,000 | 3.79% | 0.00% |
| March 26, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 11,250.0000 | 654,800,000 | 50.00% | 0.00% |
| March 26, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $70.87 | 296,705.0000 | 654,800,000 | 3.65% | 0.00% |
| Feb. 28, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 307,955.0000 | 654,800,000 | 3.79% | 0.00% |
| Feb. 28, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 22,500.0000 | 654,800,000 | 33.33% | 0.00% |
| Feb. 28, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7760 | $70.52 | 296,705.0000 | 654,800,000 | 2.55% | 0.00% |
| Feb. 28, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 3490 | $71.38 | 304,465.0000 | 654,800,000 | 1.13% | 0.00% |
| Feb. 16, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 174 | $76.19 | 296,705.0000 | 654,800,000 | 0.06% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 308,129.0000 | 654,800,000 | 3.79% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $75.76 | 296,879.0000 | 654,800,000 | 3.65% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 33,750.0000 | 654,800,000 | 25.00% | 0.00% |
| Dec. 31, 2024 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 158 | $142.06 | 4,891.0000 | 200,000,000 | 3.34% | 0.00% |
| Dec. 9, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 308,129.0000 | 654,300,000 | 3.79% | 0.00% |
| Dec. 9, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $71.68 | 296,879.0000 | 654,300,000 | 3.65% | 0.00% |
| Dec. 9, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 45,000.0000 | 654,300,000 | 20.00% | 0.00% |
| Sept. 30, 2024 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 183 | $122.78 | 4,733.0000 | 199,000,000 | 4.02% | 0.00% |
| June 28, 2024 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 205 | $109.65 | 4,550.0000 | 199,000,000 | 4.72% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 5625 | $0.00 | 56,250.0000 | 651,800,000 | 9.09% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 400 | $88.11 | 302,104.0000 | 651,800,000 | 0.13% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5225 | $87.47 | 296,879.0000 | 651,800,000 | 1.73% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 5625 | $45.28 | 302,504.0000 | 651,800,000 | 1.89% | 0.00% |
| May 21, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 5625 | $0.00 | 61,875.0000 | 651,800,000 | 8.33% | 0.00% |
| May 21, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 5625 | $45.28 | 302,504.0000 | 651,800,000 | 1.89% | 0.00% |
| May 21, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5625 | $90.45 | 296,879.0000 | 651,800,000 | 1.86% | 0.00% |
| May 16, 2024 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 2622 | $0.00 | 4,292.0000 | 199,000,000 | 157.01% | 0.00% |
| May 11, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1198 | $86.72 | 296,879.0000 | 651,800,000 | 0.40% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Employee Stock Option (Right to Acquire) | 65500 | $0.00 | 65,500.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Common Stock | 11075 | $0.00 | 298,867.0000 | 651,800,000 | 3.85% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 790 | $85.09 | 298,077.0000 | 651,800,000 | 0.26% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | A | Performance Rights | 11075 | $0.00 | 11,075.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 4, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7465 | $0.00 | 292,223.0000 | 651,800,000 | 2.62% | 0.00% |
| May 4, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 4431 | $85.25 | 287,792.0000 | 651,800,000 | 1.52% | 0.00% |
| May 4, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Performance Rights | 7465 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 634 | $85.06 | 284,758.0000 | 651,800,000 | 0.22% | 0.00% |
| April 30, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 700 | $86.40 | 291,942.0000 | 651,800,000 | 0.24% | 0.00% |
| April 30, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 6550 | $85.74 | 285,392.0000 | 651,800,000 | 2.24% | 0.00% |
| April 30, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7250 | $36.75 | 292,642.0000 | 651,800,000 | 2.54% | 0.00% |
| April 30, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7250 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| March 28, 2024 | ILLUMINA, INC. | $ILMN | Ullem Scott B. | Director | A | Common Stock | 163 | $137.68 | 1,670.0000 | 199,000,000 | 10.82% | 0.00% |
| April 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 868 | $95.51 | 291,779.0000 | 651,800,000 | 0.30% | 0.00% |
| April 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 7,250.0000 | 651,800,000 | 50.02% | 0.00% |
| April 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 6387 | $94.81 | 285,392.0000 | 651,800,000 | 2.19% | 0.00% |
| April 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,647.0000 | 651,800,000 | 2.54% | 0.00% |
| Feb. 29, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 14,505.0000 | 650,500,000 | 33.34% | 0.00% |
| Feb. 29, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,647.0000 | 650,500,000 | 2.54% | 0.00% |
| Feb. 29, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7255 | $85.59 | 285,392.0000 | 650,500,000 | 2.48% | 0.00% |
| Feb. 16, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 174 | $86.04 | 285,392.0000 | 650,500,000 | 0.06% | 0.00% |
| Feb. 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 21,760.0000 | 650,500,000 | 25.00% | 0.00% |
| Feb. 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,821.0000 | 650,500,000 | 2.54% | 0.00% |
| Feb. 1, 2024 | Edwards Lifesciences Corp | $EW | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7255 | $78.29 | 285,566.0000 | 650,500,000 | 2.48% | 0.00% |